The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro
- PMID: 9482108
- DOI: 10.1038/sj.onc.1201564
The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro
Abstract
Plasminogen activators (PAs) play an important role in tumor cell invasion. We have analysed the expression of tissue-type PA (t-PA), urokinase-type PA (u-PA), and their respective receptors, annexin II and u-PAR, in normal and neoplastic cultures of pancreatic cells, as well as in pancreatic tissues, and have examined their role in tumor invasiveness in vitro. Using Northern blotting, Western blotting, and ELISA, t-PA is detected in cultured pancreas cancer cells displaying a well differentiated phenotype but it is undetectable in less differentiated cells and in normal pancreatic cultures. In contrast, u-PA transcripts, protein, and enzymatic activity are detected both in cancer cells and in normal cultures. Higher levels of u-PAR and annexin II are present in cancer cells than in normal cultures and, in SK-PC-1 cells, both receptors are localized in the basolateral membrane. In vitro invasion assays indicate that both t-PA and u-PA contribute to the invasiveness of SK-PC-1 cells through reconstituted extracellular matrix. To determine the relevance of these studies to pancreas cancer, immunohistochemical assays have been used to examine the expression of t-PA, u-PA, and their receptors in normal and neoplastic tissues. t-PA is absent from normal pancreas and from tumor associated pancreatitis, whereas it is detected in the majority of pancreas cancer tissues (16/17). Annexin II is also overexpressed in some tumors (5/13). u-PAR is overexpressed in most tumor samples examined (14/15), while u-PA is weakly detected in a low number of cases (3/14); both u-PAR and u-PA are overexpressed in areas of tumor associated pancreatitis. Indirect evidences indicate that K-ras and p53 mutated proteins can regulate the expression of PAs. In pancreatic cancer we have found an association between codon 12 K-ras mutations and t-PA expression (P=0.04). These results support the contention that, in the exocrine pancreas, activation of t-PA is more specifically associated to neoplastic transformation and to the invasive phenotype, whereas the induction of u-PA/u-PAR system might be more relevant to inflammatory or non-neoplastic events.
Similar articles
-
Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.Alcohol Clin Exp Res. 2001 Feb;25(2):163-70. Alcohol Clin Exp Res. 2001. PMID: 11236828
-
Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.Cancer. 2006 Mar 1;106(5):1026-35. doi: 10.1002/cncr.21682. Cancer. 2006. PMID: 16435385
-
Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.Cancer Res. 1998 May 15;58(10):2234-9. Cancer Res. 1998. PMID: 9605771
-
The fibrinolytic system in neoplasia.Semin Thromb Hemost. 1996;22(6):459-78. doi: 10.1055/s-2007-999047. Semin Thromb Hemost. 1996. PMID: 9122711 Review.
-
Structure and function of the urokinase receptor.Blood Coagul Fibrinolysis. 1993 Apr;4(2):293-303. Blood Coagul Fibrinolysis. 1993. PMID: 8388742 Review.
Cited by
-
Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.Mol Cell Proteomics. 2011 Oct;10(10):M111.008599. doi: 10.1074/mcp.M111.008599. Epub 2011 Jun 7. Mol Cell Proteomics. 2011. PMID: 21653254 Free PMC article.
-
The role of annexin A2 in tumorigenesis and cancer progression.Cancer Microenviron. 2011 Aug;4(2):199-208. doi: 10.1007/s12307-011-0064-9. Epub 2011 Mar 5. Cancer Microenviron. 2011. PMID: 21909879 Free PMC article.
-
Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.Am J Pathol. 1998 Jul;153(1):201-12. doi: 10.1016/S0002-9440(10)65561-7. Am J Pathol. 1998. PMID: 9665481 Free PMC article.
-
The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets.Biomolecules. 2022 Jan 18;12(2):152. doi: 10.3390/biom12020152. Biomolecules. 2022. PMID: 35204653 Free PMC article. Review.
-
Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.Am J Pathol. 2002 May;160(5):1831-7. doi: 10.1016/S0002-9440(10)61129-7. Am J Pathol. 2002. PMID: 12000734 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous